vs

Side-by-side financial comparison of Beauty Health Co (SKIN) and TELOS CORP (TLS). Click either name above to swap in a different company.

Beauty Health Co is the larger business by last-quarter revenue ($82.4M vs $46.8M, roughly 1.8× TELOS CORP). Beauty Health Co runs the higher net margin — -9.8% vs -34.9%, a 25.0% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs -1.3%). Beauty Health Co produced more free cash flow last quarter ($15.1M vs $8.0M). Over the past eight quarters, TELOS CORP's revenue compounded faster (25.7% CAGR vs 0.6%).

Rare Beauty is an American cosmetics company founded by singer and actress Selena Gomez. Launched on September 3, 2020, the brand takes its name from Gomez’s third studio album, Rare (2020). Rare Beauty is sold through its official website, Sephora And Ulta beauty stores in multiple regions, including North America, Europe, Asia, and the Middle East.

Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.

SKIN vs TLS — Head-to-Head

Bigger by revenue
SKIN
SKIN
1.8× larger
SKIN
$82.4M
$46.8M
TLS
Growing faster (revenue YoY)
TLS
TLS
+78.7% gap
TLS
77.4%
-1.3%
SKIN
Higher net margin
SKIN
SKIN
25.0% more per $
SKIN
-9.8%
-34.9%
TLS
More free cash flow
SKIN
SKIN
$7.1M more FCF
SKIN
$15.1M
$8.0M
TLS
Faster 2-yr revenue CAGR
TLS
TLS
Annualised
TLS
25.7%
0.6%
SKIN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SKIN
SKIN
TLS
TLS
Revenue
$82.4M
$46.8M
Net Profit
$-8.1M
$-16.3M
Gross Margin
64.4%
35.0%
Operating Margin
0.2%
-39.6%
Net Margin
-9.8%
-34.9%
Revenue YoY
-1.3%
77.4%
Net Profit YoY
21.5%
-74.8%
EPS (diluted)
$-0.02
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SKIN
SKIN
TLS
TLS
Q4 25
$82.4M
$46.8M
Q3 25
$70.7M
$51.4M
Q2 25
$78.2M
$36.0M
Q1 25
$69.6M
$30.6M
Q4 24
$83.5M
$26.4M
Q3 24
$78.8M
$23.8M
Q2 24
$90.6M
$28.5M
Q1 24
$81.4M
$29.6M
Net Profit
SKIN
SKIN
TLS
TLS
Q4 25
$-8.1M
$-16.3M
Q3 25
$-11.0M
$-2.1M
Q2 25
$19.7M
$-9.5M
Q1 25
$-10.1M
$-8.6M
Q4 24
$-10.3M
$-9.3M
Q3 24
$-18.3M
$-28.1M
Q2 24
$202.0K
$-7.8M
Q1 24
$-679.0K
$-7.4M
Gross Margin
SKIN
SKIN
TLS
TLS
Q4 25
64.4%
35.0%
Q3 25
64.6%
39.9%
Q2 25
62.8%
33.2%
Q1 25
69.8%
39.8%
Q4 24
62.7%
40.3%
Q3 24
51.6%
13.2%
Q2 24
45.2%
34.1%
Q1 24
59.4%
37.0%
Operating Margin
SKIN
SKIN
TLS
TLS
Q4 25
0.2%
-39.6%
Q3 25
-8.8%
-4.8%
Q2 25
-3.5%
-27.5%
Q1 25
-17.3%
-29.5%
Q4 24
-8.6%
-37.6%
Q3 24
-27.3%
-121.4%
Q2 24
-24.4%
-30.3%
Q1 24
-20.9%
-28.5%
Net Margin
SKIN
SKIN
TLS
TLS
Q4 25
-9.8%
-34.9%
Q3 25
-15.6%
-4.1%
Q2 25
25.2%
-26.5%
Q1 25
-14.5%
-28.1%
Q4 24
-12.4%
-35.4%
Q3 24
-23.2%
-118.0%
Q2 24
0.2%
-27.2%
Q1 24
-0.8%
-24.9%
EPS (diluted)
SKIN
SKIN
TLS
TLS
Q4 25
$-0.02
$-0.22
Q3 25
$-0.09
$-0.03
Q2 25
$0.03
$-0.13
Q1 25
$-0.08
$-0.12
Q4 24
$-0.01
$-0.13
Q3 24
$-0.15
$-0.39
Q2 24
$-0.10
$-0.11
Q1 24
$-0.10
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SKIN
SKIN
TLS
TLS
Cash + ST InvestmentsLiquidity on hand
$53.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$61.1M
$96.0M
Total Assets
$499.8M
$139.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SKIN
SKIN
TLS
TLS
Q4 25
$53.2M
Q3 25
$59.0M
Q2 25
$57.0M
Q1 25
$57.8M
Q4 24
$54.6M
Q3 24
$69.8M
Q2 24
$80.1M
Q1 24
$93.9M
Total Debt
SKIN
SKIN
TLS
TLS
Q4 25
Q3 25
$363.4M
Q2 25
$363.1M
Q1 25
Q4 24
$552.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
SKIN
SKIN
TLS
TLS
Q4 25
$61.1M
$96.0M
Q3 25
$65.7M
$119.7M
Q2 25
$74.0M
$118.4M
Q1 25
$46.1M
$126.1M
Q4 24
$51.8M
$127.1M
Q3 24
$59.7M
$129.5M
Q2 24
$69.2M
$149.1M
Q1 24
$63.3M
$154.4M
Total Assets
SKIN
SKIN
TLS
TLS
Q4 25
$499.8M
$139.9M
Q3 25
$503.6M
$164.3M
Q2 25
$507.6M
$165.0M
Q1 25
$673.8M
$158.1M
Q4 24
$685.7M
$158.2M
Q3 24
$699.5M
$166.3M
Q2 24
$711.8M
$182.4M
Q1 24
$844.7M
$195.4M
Debt / Equity
SKIN
SKIN
TLS
TLS
Q4 25
Q3 25
5.53×
Q2 25
4.91×
Q1 25
Q4 24
10.66×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SKIN
SKIN
TLS
TLS
Operating Cash FlowLast quarter
$15.2M
$8.0M
Free Cash FlowOCF − Capex
$15.1M
$8.0M
FCF MarginFCF / Revenue
18.3%
17.0%
Capex IntensityCapex / Revenue
0.2%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$37.2M
$29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SKIN
SKIN
TLS
TLS
Q4 25
$15.2M
$8.0M
Q3 25
$9.6M
$9.1M
Q2 25
$9.6M
$7.0M
Q1 25
$3.0M
$6.1M
Q4 24
$16.5M
$-10.5M
Q3 24
$10.3M
$-7.1M
Q2 24
$6.2M
$-8.0M
Q1 24
$-16.9M
$-350.0K
Free Cash Flow
SKIN
SKIN
TLS
TLS
Q4 25
$15.1M
$8.0M
Q3 25
$9.6M
$8.7M
Q2 25
$9.6M
$6.8M
Q1 25
$3.0M
$6.0M
Q4 24
$16.4M
$-12.4M
Q3 24
$10.3M
$-7.1M
Q2 24
$5.9M
$-8.2M
Q1 24
$-17.2M
$-447.0K
FCF Margin
SKIN
SKIN
TLS
TLS
Q4 25
18.3%
17.0%
Q3 25
13.6%
16.9%
Q2 25
12.2%
19.0%
Q1 25
4.2%
19.5%
Q4 24
19.6%
-47.0%
Q3 24
13.1%
-30.0%
Q2 24
6.5%
-28.9%
Q1 24
-21.1%
-1.5%
Capex Intensity
SKIN
SKIN
TLS
TLS
Q4 25
0.2%
0.1%
Q3 25
0.0%
0.9%
Q2 25
0.1%
0.4%
Q1 25
0.1%
0.4%
Q4 24
0.1%
7.1%
Q3 24
0.0%
0.2%
Q2 24
0.4%
0.8%
Q1 24
0.4%
0.3%
Cash Conversion
SKIN
SKIN
TLS
TLS
Q4 25
Q3 25
Q2 25
0.49×
Q1 25
Q4 24
Q3 24
Q2 24
30.70×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SKIN
SKIN

Consumables$57.7M70%
Delivery Systems$24.7M30%

TLS
TLS

Security Solutions Segment$44.8M96%
Secure Networks Segment$1.9M4%

Related Comparisons